These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 28537315)
21. Synthesis of benzothiophene-based hydroxamic acids as potent and selective HDAC6 inhibitors. De Vreese R; Van Steen N; Verhaeghe T; Desmet T; Bougarne N; De Bosscher K; Benoy V; Haeck W; Van Den Bosch L; D'hooghe M Chem Commun (Camb); 2015 Jun; 51(48):9868-71. PubMed ID: 25994553 [TBL] [Abstract][Full Text] [Related]
22. An efficient synthesis of SK-658 and its analogs as potent histone deacetylase inhibitors. Shahidul Islam M; Nurul Islam M; Ashraful Hoque M; Nishino N; Kato T; Kim HJ; Ito A; Yoshida M Bioorg Chem; 2015 Apr; 59():145-50. PubMed ID: 25797804 [TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological activity of hydroxamic tertiary amines as histone deacetylase inhibitors. Terracciano S; Chini MG; Riccio R; Bruno I; Bifulco G ChemMedChem; 2012 Apr; 7(4):694-702. PubMed ID: 22278987 [TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors. Pabba C; Gregg BT; Kitchen DB; Chen ZJ; Judkins A Bioorg Med Chem Lett; 2011 Jan; 21(1):324-8. PubMed ID: 21109435 [TBL] [Abstract][Full Text] [Related]
25. Computational exploration of zinc binding groups for HDAC inhibition. Chen K; Xu L; Wiest O J Org Chem; 2013 May; 78(10):5051-5. PubMed ID: 23586590 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of Santacruzamate-A based analogues. Randino R; Gazzerro P; Mazitschek R; Rodriquez M Bioorg Med Chem; 2017 Dec; 25(24):6486-6491. PubMed ID: 29100734 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of N'-propylhydrazide analogs of hydroxamic inhibitors of histone deacetylases (HDACs) and evaluation of their impact on activities of HDACs and replication of hepatitis C virus (HCV). Kozlov MV; Konduktorov KA; Shcherbakova AS; Kochetkov SN Bioorg Med Chem Lett; 2019 Aug; 29(16):2369-2374. PubMed ID: 31201063 [TBL] [Abstract][Full Text] [Related]
28. Innovative Strategies for Selective Inhibition of Histone Deacetylases. Maolanon AR; Madsen AS; Olsen CA Cell Chem Biol; 2016 Jul; 23(7):759-768. PubMed ID: 27447046 [TBL] [Abstract][Full Text] [Related]
29. Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors. Cai J; Wei H; Hong KH; Wu X; Cao M; Zong X; Li L; Sun C; Chen J; Ji M Eur J Med Chem; 2015; 96():1-13. PubMed ID: 25874326 [TBL] [Abstract][Full Text] [Related]
30. 2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors. Jones P; Bottomley MJ; Carfí A; Cecchetti O; Ferrigno F; Lo Surdo P; Ontoria JM; Rowley M; Scarpelli R; Schultz-Fademrecht C; Steinkühler C Bioorg Med Chem Lett; 2008 Jun; 18(11):3456-61. PubMed ID: 18440229 [TBL] [Abstract][Full Text] [Related]
31. Lactam based 7-amino suberoylamide hydroxamic acids as potent HDAC inhibitors. Taddei M; Cini E; Giannotti L; Giannini G; Battistuzzi G; Vignola D; Vesci L; Cabri W Bioorg Med Chem Lett; 2014 Jan; 24(1):61-4. PubMed ID: 24345446 [TBL] [Abstract][Full Text] [Related]
32. Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif. Guan P; Wang L; Hou X; Wan Y; Xu W; Tang W; Fang H Bioorg Med Chem; 2014 Nov; 22(21):5766-75. PubMed ID: 25311567 [TBL] [Abstract][Full Text] [Related]
33. 2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors. Muraglia E; Altamura S; Branca D; Cecchetti O; Ferrigno F; Orsale MV; Palumbi MC; Rowley M; Scarpelli R; Steinkühler C; Jones P Bioorg Med Chem Lett; 2008 Dec; 18(23):6083-7. PubMed ID: 18930398 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity. Chetan B; Bunha M; Jagrat M; Sinha BN; Saiko P; Graser G; Szekeres T; Raman G; Rajendran P; Moorthy D; Basu A; Jayaprakash V Bioorg Med Chem Lett; 2010 Jul; 20(13):3906-10. PubMed ID: 20605448 [TBL] [Abstract][Full Text] [Related]
38. Inhibitors of histone deacetylase as antitumor agents: A critical review. Manal M; Chandrasekar MJ; Gomathi Priya J; Nanjan MJ Bioorg Chem; 2016 Aug; 67():18-42. PubMed ID: 27239721 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and docking studies on benzamide derivatives as histone deacetylase inhibitors. Lu A; Luo H; Shi M; Wu G; Yuan Y; Liu J; Tang F Bioorg Med Chem Lett; 2011 Aug; 21(16):4924-7. PubMed ID: 21741834 [TBL] [Abstract][Full Text] [Related]